New drug K9 tested for thyroid eye disease – early results show promise
Symptom relief
Terminated
This early study tested a new drug called K9 in a small group of people with thyroid eye disease (TED). The main goal was to check safety and how the drug works in the body. Participants took K9 twice a day for up to 24 weeks, and researchers tracked side effects and changes in d…
Phase: PHASE1 • Sponsor: Peter Timoney • Aim: Symptom relief
Last updated May 17, 2026 10:26 UTC